EMEA (Europe, Middle East and Africa) Aurora Kinase B Market Report 2017

December 2017 | 109 pages | ID: EE471B9643FEN
QYResearch

Abstracts

In this report, the EMEA Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Aurora Kinase B for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Aurora Kinase B market competition by top manufacturers/players, with Aurora Kinase B sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie Inc
• Advenchen Laboratories LLC
• Aeterna Zentaris Inc
• Amgen Inc
• AstraZeneca Plc
• Chipscreen Biosciences Ltd
• Cielo Therapeutics Inc
• Sanofi
• Sareum Holdings Plc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• AZD-2811
• CS-2164
• Danusertib
• Ilorasertib
• NMI-900
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Anaplastic Large Cell Lymphoma
• Kidney Cancer
• Lung Cancer
• Prostate Cancer
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Aurora Kinase B Market Report 2017

1 AURORA KINASE B OVERVIEW

1.1 Product Overview and Scope of Aurora Kinase B
1.2 Classification of Aurora Kinase B
  1.2.1 EMEA Aurora Kinase B Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Aurora Kinase B Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 AZD-2811
  1.2.4 CS-2164
  1.2.5 Danusertib
  1.2.6 Ilorasertib
  1.2.7 NMI-900
  1.2.8 Others
1.3 EMEA Aurora Kinase B Market by Application/End Users
  1.3.1 EMEA Aurora Kinase B Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Anaplastic Large Cell Lymphoma
  1.3.3 Kidney Cancer
  1.3.4 Lung Cancer
  1.3.5 Prostate Cancer
  1.3.6 Others
1.4 EMEA Aurora Kinase B Market by Region
  1.4.1 EMEA Aurora Kinase B Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Aurora Kinase B (2012-2022)
  1.5.1 EMEA Aurora Kinase B Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Aurora Kinase B Revenue and Growth Rate (2012-2022)

2 EMEA AURORA KINASE B COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Aurora Kinase B Market Competition by Players/Manufacturers
  2.1.1 EMEA Aurora Kinase B Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Aurora Kinase B Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Aurora Kinase B Sale Price by Players (2012-2017)
2.2 EMEA Aurora Kinase B (Volume and Value) by Type/Product Category
  2.2.1 EMEA Aurora Kinase B Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Aurora Kinase B Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Aurora Kinase B Sale Price by Type (2012-2017)
2.3 EMEA Aurora Kinase B (Volume) by Application
2.4 EMEA Aurora Kinase B (Volume and Value) by Region
  2.4.1 EMEA Aurora Kinase B Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Aurora Kinase B Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Aurora Kinase B Sales Price by Region (2012-2017)

3 EUROPE AURORA KINASE B (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Aurora Kinase B Sales and Value (2012-2017)
  3.1.1 Europe Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Aurora Kinase B Revenue and Growth Rate (2012-2017)
3.2 Europe Aurora Kinase B Sales and Market Share by Type
3.3 Europe Aurora Kinase B Sales and Market Share by Application
3.4 Europe Aurora Kinase B Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Aurora Kinase B Sales Volume by Countries (2012-2017)
  3.4.2 Europe Aurora Kinase B Revenue by Countries (2012-2017)
  3.4.3 Germany Aurora Kinase B Sales and Growth Rate (2012-2017)
  3.4.4 France Aurora Kinase B Sales and Growth Rate (2012-2017)
  3.4.5 UK Aurora Kinase B Sales and Growth Rate (2012-2017)
  3.4.6 Russia Aurora Kinase B Sales and Growth Rate (2012-2017)
  3.4.7 Italy Aurora Kinase B Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Aurora Kinase B Sales and Growth Rate (2012-2017)

4 MIDDLE EAST AURORA KINASE B (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Aurora Kinase B Sales and Value (2012-2017)
  4.1.1 Middle East Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Aurora Kinase B Revenue and Growth Rate (2012-2017)
4.2 Middle East Aurora Kinase B Sales and Market Share by Type
4.3 Middle East Aurora Kinase B Sales and Market Share by Application
4.4 Middle East Aurora Kinase B Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Aurora Kinase B Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Aurora Kinase B Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Aurora Kinase B Sales and Growth Rate (2012-2017)
  4.4.4 Israel Aurora Kinase B Sales and Growth Rate (2012-2017)
  4.4.5 UAE Aurora Kinase B Sales and Growth Rate (2012-2017)
  4.4.6 Iran Aurora Kinase B Sales and Growth Rate (2012-2017)

5 AFRICA AURORA KINASE B (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Aurora Kinase B Sales and Value (2012-2017)
  5.1.1 Africa Aurora Kinase B Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Aurora Kinase B Revenue and Growth Rate (2012-2017)
5.2 Africa Aurora Kinase B Sales and Market Share by Type
5.3 Africa Aurora Kinase B Sales and Market Share by Application
5.4 Africa Aurora Kinase B Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Aurora Kinase B Sales Volume by Countries (2012-2017)
  5.4.2 Africa Aurora Kinase B Revenue by Countries (2012-2017)
  5.4.3 South Africa Aurora Kinase B Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Aurora Kinase B Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Aurora Kinase B Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Aurora Kinase B Sales and Growth Rate (2012-2017)

6 EMEA AURORA KINASE B MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AbbVie Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Aurora Kinase B Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Advenchen Laboratories LLC
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Aurora Kinase B Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Aeterna Zentaris Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Aurora Kinase B Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Aurora Kinase B Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca Plc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Aurora Kinase B Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Chipscreen Biosciences Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Aurora Kinase B Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cielo Therapeutics Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Aurora Kinase B Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Aurora Kinase B Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sareum Holdings Plc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Aurora Kinase B Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 AURORA KINASE B MANUFACTURING COST ANALYSIS

7.1 Aurora Kinase B Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Aurora Kinase B

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Aurora Kinase B Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA AURORA KINASE B MARKET FORECAST (2017-2022)

11.1 EMEA Aurora Kinase B Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Aurora Kinase B Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Aurora Kinase B Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Aurora Kinase B Price and Trend Forecast (2017-2022)
11.2 EMEA Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Aurora Kinase B Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Aurora Kinase B Sales Forecast by Type (2017-2022)
11.7 EMEA Aurora Kinase B Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Aurora Kinase B
Figure EMEA Aurora Kinase B Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Aurora Kinase B Sales Volume Market Share by Type (Product Category) in 2016
Figure AZD-2811 Product Picture
Figure CS-2164 Product Picture
Figure Danusertib Product Picture
Figure Ilorasertib Product Picture
Figure NMI-900 Product Picture
Figure Others Product Picture
Figure EMEA Aurora Kinase B Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Aurora Kinase B by Application in 2016
Figure Anaplastic Large Cell Lymphoma Examples
Table Key Downstream Customer in Anaplastic Large Cell Lymphoma
Figure Kidney Cancer Examples
Table Key Downstream Customer in Kidney Cancer
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Aurora Kinase B Market Size (Million USD) by Region (2012-2022)
Figure Europe Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Aurora Kinase B Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Aurora Kinase B Revenue (Million USD) Status and Forecast by Countries
Figure Africa Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Aurora Kinase B Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Aurora Kinase B Sales Volume and Growth Rate (2012-2022)
Figure EMEA Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Aurora Kinase B Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Aurora Kinase B Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Aurora Kinase B Sales Share by Players (2012-2017)
Figure 2016 Aurora Kinase B Sales Share by Players
Figure 2017 Aurora Kinase B Sales Share by Players
Figure EMEA Aurora Kinase B Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Aurora Kinase B Revenue (Million USD) by Players (2012-2017)
Table EMEA Aurora Kinase B Revenue Share by Players (2012-2017)
Table 2016 EMEA Aurora Kinase B Revenue Share by Players
Table 2017 EMEA Aurora Kinase B Revenue Share by Players
Table EMEA Aurora Kinase B Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Aurora Kinase B Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Aurora Kinase B Sales Share by Type (2012-2017)
Figure Sales Market Share of Aurora Kinase B by Type (2012-2017)
Figure EMEA Aurora Kinase B Sales Market Share by Type (2012-2017)
Table EMEA Aurora Kinase B Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Aurora Kinase B Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase B by Type in 2016
Table EMEA Aurora Kinase B Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Aurora Kinase B Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Aurora Kinase B Sales Share by Application (2012-2017)
Figure Sales Market Share of Aurora Kinase B by Application (2012-2017)
Figure EMEA Aurora Kinase B Sales Market Share by Application in 2016
Table EMEA Aurora Kinase B Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Aurora Kinase B Sales Share by Region (2012-2017)
Figure Sales Market Share of Aurora Kinase B by Region (2012-2017)
Figure EMEA Aurora Kinase B Sales Market Share in 2016
Table EMEA Aurora Kinase B Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Aurora Kinase B Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Aurora Kinase B by Region (2012-2017)
Figure EMEA Aurora Kinase B Revenue Market Share Regions in 2016
Table EMEA Aurora Kinase B Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Aurora Kinase B Revenue and Growth Rate (2012-2017)
Table Europe Aurora Kinase B Sales (K Pcs) by Type (2012-2017)
Table Europe Aurora Kinase B Market Share by Type (2012-2017)
Figure Europe Aurora Kinase B Market Share by Type in 2016
Table Europe Aurora Kinase B Sales (K Pcs) by Application (2012-2017)
Table Europe Aurora Kinase B Market Share by Application (2012-2017)
Figure Europe Aurora Kinase B Market Share by Application in 2016
Table Europe Aurora Kinase B Sales (K Pcs) by Countries (2012-2017)
Table Europe Aurora Kinase B Sales Market Share by Countries (2012-2017)
Figure Europe Aurora Kinase B Sales Market Share by Countries (2012-2017)
Figure Europe Aurora Kinase B Sales Market Share by Countries in 2016
Table Europe Aurora Kinase B Revenue (Million USD) by Countries (2012-2017)
Table Europe Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Europe Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Europe Aurora Kinase B Revenue Market Share by Countries in 2016
Figure Germany Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Aurora Kinase B Sales (K Pcs) by Type (2012-2017)
Table Middle East Aurora Kinase B Market Share by Type (2012-2017)
Figure Middle East Aurora Kinase B Market Share by Type (2012-2017)
Table Middle East Aurora Kinase B Sales (K Pcs) by Applications (2012-2017)
Table Middle East Aurora Kinase B Market Share by Applications (2012-2017)
Figure Middle East Aurora Kinase B Sales Market Share by Application in 2016
Table Middle East Aurora Kinase B Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Aurora Kinase B Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Aurora Kinase B Sales Volume Market Share by Countries in 2016
Table Middle East Aurora Kinase B Revenue (Million USD) by Countries (2012-2017)
Table Middle East Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Middle East Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Middle East Aurora Kinase B Revenue Market Share by Countries in 2016
Figure Saudi Arabia Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Aurora Kinase B Sales (K Pcs) by Type (2012-2017)
Table Africa Aurora Kinase B Sales Market Share by Type (2012-2017)
Figure Africa Aurora Kinase B Sales Market Share by Type (2012-2017)
Figure Africa Aurora Kinase B Sales Market Share by Type in 2016
Table Africa Aurora Kinase B Sales (K Pcs) by Application (2012-2017)
Table Africa Aurora Kinase B Sales Market Share by Application (2012-2017)
Figure Africa Aurora Kinase B Sales Market Share by Application (2012-2017)
Table Africa Aurora Kinase B Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Aurora Kinase B Sales Market Share by Countries (2012-2017)
Figure Africa Aurora Kinase B Sales Market Share by Countries (2012-2017)
Figure Africa Aurora Kinase B Sales Market Share by Countries in 2016
Table Africa Aurora Kinase B Revenue (Million USD) by Countries (2012-2017)
Table Africa Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Africa Aurora Kinase B Revenue Market Share by Countries (2012-2017)
Figure Africa Aurora Kinase B Revenue Market Share by Countries in 2016
Figure South Africa Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Table AbbVie Inc Aurora Kinase B Basic Information List
Table AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Inc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Inc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure AbbVie Inc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Advenchen Laboratories LLC Aurora Kinase B Basic Information List
Table Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Aeterna Zentaris Inc Aurora Kinase B Basic Information List
Table Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc Aurora Kinase B Basic Information List
Table Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Inc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Plc Aurora Kinase B Basic Information List
Table AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Chipscreen Biosciences Ltd Aurora Kinase B Basic Information List
Table Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Cielo Therapeutics Inc Aurora Kinase B Basic Information List
Table Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Sanofi Aurora Kinase B Basic Information List
Table Sanofi Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Sanofi Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Sareum Holdings Plc Aurora Kinase B Basic Information List
Table Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Sales Market Share in EMEA (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Aurora Kinase B
Figure Manufacturing Process Analysis of Aurora Kinase B
Figure Aurora Kinase B Industrial Chain Analysis
Table Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2016
Table Major Buyers of Aurora Kinase B
Table Distributors/Traders List
Figure EMEA Aurora Kinase B Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Aurora Kinase B Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Aurora Kinase B Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Aurora Kinase B Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Aurora Kinase B Sales Market Share Forecast by Region (2017-2022)
Table EMEA Aurora Kinase B Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Aurora Kinase B Revenue Market Share Forecast by Region (2017-2022)
Table Europe Aurora Kinase B Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Aurora Kinase B Sales Market Share Forecast by Countries (2017-2022)
Table Europe Aurora Kinase B Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Aurora Kinase B Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Aurora Kinase B Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Aurora Kinase B Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Aurora Kinase B Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Aurora Kinase B Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Aurora Kinase B Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Aurora Kinase B Sales Market Share Forecast by Countries (2017-2022)
Table Africa Aurora Kinase B Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Aurora Kinase B Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Aurora Kinase B Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Aurora Kinase B Sales Market Share Forecast by Type (2017-2022)
Table EMEA Aurora Kinase B Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Aurora Kinase B Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources